Alterations on monoamines concentration in rat hippocampus produced by lipoic acid

Detalhes bibliográficos
Autor(a) principal: Santos,Ítala Mônica de Sales
Data de Publicação: 2010
Outros Autores: Freitas,Rizângela Lyne Mendes de, Saldanha,Gláucio Barros, Tomé,Adriana da Rocha, Jordán,Joaquín, Freitas,Rivelilson Mendes de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Arquivos de neuro-psiquiatria (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000300006
Resumo: The purposes of the present study were to verify monoamines (dopamine (DA), norepinephrine (NE), serotonin (5-HT)), and their metabolites (3,4-hydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA)) contents in rat hippocampus after lipoic acid (LA) administration. Wistar rats were treated with 0.9% saline (i.p., control group) and LA (10, 20 or 30 mg/kg, i.p., LA10, LA20 and LA30 groups, respectively). After the treatments all groups were observed for 24 h. The NE and DA levels were increased only in 20 mg/kg dose of LA in rat hippocampus. Serotonin content and in their metabolite 5-HIAA levels was decreased in same dose of LA. On the other hand, in DOPAC and HVA levels did not show any significant change. The alterations in hippocampal monoamines can be suggested as a possible of brain mechanism of action from this antioxidant. The outcome of the study may have therapeutic implications in the treatment of neurodegenerative diseases.
id ABNEURO-1_1bd25eb26bacc25da4f07a19d74d2c90
oai_identifier_str oai:scielo:S0004-282X2010000300006
network_acronym_str ABNEURO-1
network_name_str Arquivos de neuro-psiquiatria (Online)
repository_id_str
spelling Alterations on monoamines concentration in rat hippocampus produced by lipoic acidlipoic acidhippocampusdopaminenorepinephrineserotoninThe purposes of the present study were to verify monoamines (dopamine (DA), norepinephrine (NE), serotonin (5-HT)), and their metabolites (3,4-hydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA)) contents in rat hippocampus after lipoic acid (LA) administration. Wistar rats were treated with 0.9% saline (i.p., control group) and LA (10, 20 or 30 mg/kg, i.p., LA10, LA20 and LA30 groups, respectively). After the treatments all groups were observed for 24 h. The NE and DA levels were increased only in 20 mg/kg dose of LA in rat hippocampus. Serotonin content and in their metabolite 5-HIAA levels was decreased in same dose of LA. On the other hand, in DOPAC and HVA levels did not show any significant change. The alterations in hippocampal monoamines can be suggested as a possible of brain mechanism of action from this antioxidant. The outcome of the study may have therapeutic implications in the treatment of neurodegenerative diseases.Academia Brasileira de Neurologia - ABNEURO2010-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000300006Arquivos de Neuro-Psiquiatria v.68 n.3 2010reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/S0004-282X2010000300006info:eu-repo/semantics/openAccessSantos,Ítala Mônica de SalesFreitas,Rizângela Lyne Mendes deSaldanha,Gláucio BarrosTomé,Adriana da RochaJordán,JoaquínFreitas,Rivelilson Mendes deeng2010-06-24T00:00:00Zoai:scielo:S0004-282X2010000300006Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2010-06-24T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse
dc.title.none.fl_str_mv Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
title Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
spellingShingle Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
Santos,Ítala Mônica de Sales
lipoic acid
hippocampus
dopamine
norepinephrine
serotonin
title_short Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
title_full Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
title_fullStr Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
title_full_unstemmed Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
title_sort Alterations on monoamines concentration in rat hippocampus produced by lipoic acid
author Santos,Ítala Mônica de Sales
author_facet Santos,Ítala Mônica de Sales
Freitas,Rizângela Lyne Mendes de
Saldanha,Gláucio Barros
Tomé,Adriana da Rocha
Jordán,Joaquín
Freitas,Rivelilson Mendes de
author_role author
author2 Freitas,Rizângela Lyne Mendes de
Saldanha,Gláucio Barros
Tomé,Adriana da Rocha
Jordán,Joaquín
Freitas,Rivelilson Mendes de
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Santos,Ítala Mônica de Sales
Freitas,Rizângela Lyne Mendes de
Saldanha,Gláucio Barros
Tomé,Adriana da Rocha
Jordán,Joaquín
Freitas,Rivelilson Mendes de
dc.subject.por.fl_str_mv lipoic acid
hippocampus
dopamine
norepinephrine
serotonin
topic lipoic acid
hippocampus
dopamine
norepinephrine
serotonin
description The purposes of the present study were to verify monoamines (dopamine (DA), norepinephrine (NE), serotonin (5-HT)), and their metabolites (3,4-hydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA)) contents in rat hippocampus after lipoic acid (LA) administration. Wistar rats were treated with 0.9% saline (i.p., control group) and LA (10, 20 or 30 mg/kg, i.p., LA10, LA20 and LA30 groups, respectively). After the treatments all groups were observed for 24 h. The NE and DA levels were increased only in 20 mg/kg dose of LA in rat hippocampus. Serotonin content and in their metabolite 5-HIAA levels was decreased in same dose of LA. On the other hand, in DOPAC and HVA levels did not show any significant change. The alterations in hippocampal monoamines can be suggested as a possible of brain mechanism of action from this antioxidant. The outcome of the study may have therapeutic implications in the treatment of neurodegenerative diseases.
publishDate 2010
dc.date.none.fl_str_mv 2010-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000300006
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2010000300006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0004-282X2010000300006
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
publisher.none.fl_str_mv Academia Brasileira de Neurologia - ABNEURO
dc.source.none.fl_str_mv Arquivos de Neuro-Psiquiatria v.68 n.3 2010
reponame:Arquivos de neuro-psiquiatria (Online)
instname:Academia Brasileira de Neurologia
instacron:ABNEURO
instname_str Academia Brasileira de Neurologia
instacron_str ABNEURO
institution ABNEURO
reponame_str Arquivos de neuro-psiquiatria (Online)
collection Arquivos de neuro-psiquiatria (Online)
repository.name.fl_str_mv Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia
repository.mail.fl_str_mv ||revista.arquivos@abneuro.org
_version_ 1754212768501727232